273 related articles for article (PubMed ID: 16575682)
1. Thrombotic thrombocytopenic purpura--then and now.
Galbusera M; Noris M; Remuzzi G
Semin Thromb Hemost; 2006 Mar; 32(2):81-9. PubMed ID: 16575682
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic thrombocytopenic purpura: survival by "giving a dam".
Moake JL
Trans Am Clin Climatol Assoc; 2004; 115():201-19. PubMed ID: 17060968
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
Manea M; Karpman D
Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
[TBL] [Abstract][Full Text] [Related]
5. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Moake JL
Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
[TBL] [Abstract][Full Text] [Related]
7. [ADAMTS13-Mediated Proteolytic Cleavage of Unusually Large von Willebrand Factor Polymers on Endothelial Cells in the Absence of Fluid Shear Stress].
Zhao SC; Li H; Wang M; Zhao YH; Li XJ; Jin SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):532-540. PubMed ID: 38660863
[TBL] [Abstract][Full Text] [Related]
8. Generation and breakdown of soluble ultralarge von Willebrand factor multimers.
Turner N; Nolasco L; Moake J
Semin Thromb Hemost; 2012 Feb; 38(1):38-46. PubMed ID: 22314602
[TBL] [Abstract][Full Text] [Related]
9. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.
Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F
Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
Lian EC
Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
[TBL] [Abstract][Full Text] [Related]
12. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura and anti-thrombotic therapy targeted to von Willebrand factor.
Zhou Z; Dong JF
Curr Vasc Pharmacol; 2012 Nov; 10(6):762-6. PubMed ID: 22022775
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
15. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
Budde U; Schneppenheim R
Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
[TBL] [Abstract][Full Text] [Related]
16. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
George JN
Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare.
Moake JL; Chow TW
Am J Med Sci; 1998 Aug; 316(2):105-19. PubMed ID: 9704664
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of thrombotic thrombocytopenic purpura.
Tsai HM
Int J Hematol; 2010 Jan; 91(1):1-19. PubMed ID: 20058209
[TBL] [Abstract][Full Text] [Related]
19. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Zhou Z; Nguyen TC; Guchhait P; Dong JF
Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
